GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) » Definitions » Dividend Yield %

Hangzhou Tigermed Consulting Co (HKSE:03347) Dividend Yield % : 1.85% (As of Dec. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Dividend Yield %?

As of today (2024-12-15), the Trailing Annual Dividend Yield of Hangzhou Tigermed Consulting Co is 1.85%.

The historical rank and industry rank for Hangzhou Tigermed Consulting Co's Dividend Yield % or its related term are showing as below:

HKSE:03347' s Dividend Yield % Range Over the Past 10 Years
Min: 0.14   Med: 0.39   Max: 1.85
Current: 1.85

During the past 13 years, the highest Dividend Yield of Hangzhou Tigermed Consulting Co was 1.85%. The lowest was 0.14%. And the median was 0.39%.

HKSE:03347's Dividend Yield % is ranked worse than
64.18% of 67 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.27 vs HKSE:03347: 1.85

Hangzhou Tigermed Consulting Co's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Hangzhou Tigermed Consulting Co was 0.64. The lowest was 0.21. And the median was 0.31.

As of today (2024-12-15), the Forward Dividend Yield % of Hangzhou Tigermed Consulting Co is 1.85%.

Hangzhou Tigermed Consulting Co's Dividends per Share for the three months ended in Sep. 2024 was HK$0.00.

During the past 12 months, Hangzhou Tigermed Consulting Co's average Dividends Per Share Growth Rate was 3.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 25.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 31.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 22.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hangzhou Tigermed Consulting Co was 60.70% per year. The lowest was -20.40% per year. And the median was 30.05% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Hangzhou Tigermed Consulting Co Dividend Yield % Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Dividend Yield % Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.37 0.64 1.74

Hangzhou Tigermed Consulting Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 1.74 2.08 2.26 1.56

Competitive Comparison of Hangzhou Tigermed Consulting Co's Dividend Yield %

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Dividend Yield % falls into.



Hangzhou Tigermed Consulting Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Hangzhou Tigermed Consulting Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.6236502024-06-072024-06-122024-07-18Cash DividendannuallyHKD:HKD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Hangzhou Tigermed Consulting Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.62365/33.80
=1.85 %

Current Share Price is HK$33.80.
Hangzhou Tigermed Consulting Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.62365.

Hangzhou Tigermed Consulting Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.62365/33.80
=1.85 %

Current Share Price is HK$33.80.
Hangzhou Tigermed Consulting Co's Dividends per Share for the forward twelve months is calculated as HK$0.62365 * 1 = HK$0.62365.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Tigermed Consulting Co  (HKSE:03347) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Hangzhou Tigermed Consulting Co Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Executives
Yi Fang Da Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Sands Capital Management, Llc 2101 Beneficial owner
Sands Capital Management, Lp 2201 Interest of corporation controlled by you
Sands Family Trust, Llc 2201 Interest of corporation controlled by you
Sands Frank Melville Jr. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
F-j Sands Family I, Llc 2201 Interest of corporation controlled by you
2017 Eagle Holdings Llc 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Ubs Group Ag 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Ninety One Plc/ Ninety One Ltd 2102 Investment manager
Ninety One Uk Limited 2102 Investment manager
Baillie Gifford & Co 2102 Investment manager

Hangzhou Tigermed Consulting Co Headlines

No Headlines